According to a series of news agencies, more details regarding the DePuy hip implants have surfaced during trial.
Reports indicate that the same executive who assumed the DePuy division after the major recall of the flawed hip implants is the same executive who supervised the implant’s design and introduction. According to the news, this same executive was holding one of the senior marketing positions when the company Johnson & Johnson refrained from reporting officials outside of the country that U.S. regulatory agencies had refused to allow the company to sell the potentially flawed hip implant in the country.
The all-metal hip implant that has been linked to a series of complaints and revision surgeries is under fire during the trial of the first lawsuit out of 10,000 filed against J&J. The Articular Surface Replacement, or A.S.R. is the main device associated with the 10,000 lawsuits filed against DePuy. According to the news, the involvement of the same executive in the supervision of the implant’s introduction is being brought up during the trial. This issue could raise questions concerning DePuy’s ability to put this matter behind them and efficiently work on designing devices that meet high safety standards. According to a DePuy spokesperson, the company only seeks the most competent people for the job. Multiple marketing executives were called to testify. Executives who were involved in the A.S.R. development will be testifying in the near future. According to those who testified last Wednesday, the devices were recalled over a failure to meet clinical standards.
Before the recall announcement, DePuy executives claimed publicly that all devices performed well in spite of the fact that, internal documents show conflict information regarding how well these devices were working then.
Towards the end of 2008, one of DePuy’s top consultant surgeons contacted some DePuy marketing officials due to a concern regarding the device’s cup design. According to the surgeon, the cup should be redesigned due to a failure that could eventually pose health hazards to recipients.
These devices were first sold outside of the country in 2003 for use as an alternative replacement procedure known as resurfacing. Several complaints and revision surgeries were reported in the country and abroad. The first lawsuit in 10,000 is being tried now in Los Angeles.
To learn more about the details that have surfaced during trial, click here for the full article or watch the video below: